USPTO serial 79213572
RPRO TECHNOLOGY
Reviewed by CopyMark Law Group
Reg. 5923203Status 709
- Filing date
- Status date
- Registration date
- Dec 3, 2019
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RPRO TECHNOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
F-91940 LES ULIS, FR
Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
F-91940 LES ULIS, FR
Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
F-91940 LES ULIS, FR
Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monte L. Falcoff/Jessica S. Sachs
Monte L. Falcoff/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services, namely, laboratory research relating to the design of new pharmaceutical products and therapeutic protein-based medicines for others; design and development of new pharmaceutical products and therapeutic protein-based medicines for others utilizing recombinant DNA technologies; consulting services in the fields of pharmaceutical research and development, including therapeutic protein-based pharmaceutical research and development, and laboratory testing, diagnostics and pharmacogenetics related thereto; engineering; scientific laboratory services utilizing computer software platforms and recombinant DNA technologies for the development and optimization of pharmaceutical products, including therapeutic protein-based medicines, and laboratory analysis and laboratory research related thereto | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Other trademarks in Class 042
- Similar marks named RPRO TECHNOLOGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 19, 2026 | C71T | CANCELLED SECTION 71 | — |
| Dec 3, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 4, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 27, 2021 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 3, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 29, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 21, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 21, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 3, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 3, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 17, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 17, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 28, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 28, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 9, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 1, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 1, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 1, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 1, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 30, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 25, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 9, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 9, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 30, 2018 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 30, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 30, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 30, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 25, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 10, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 10, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 4, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 4, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 3, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |